What are the latest figures on the kyphoscoliosis treatment market’s size and projected CAGR?
The kyphoscoliosis treatment market size has grown strongly in recent years. It will grow from $3.08 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to exploration of regenerative medicine, genetic research contributions, telemedicine and remote monitoring, advancements in rehabilitation programs.
The kyphoscoliosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to personalized treatment approaches, expansion of biomechanical research, remote monitoring and telehealth services, continued genetic research. Major trends in the forecast period include advanced surgical techniques, innovative bracing technologies, customized treatment plans, adoption of 3D printing, pain management innovations.
Get Your Free Sample of The Global Kyphoscoliosis Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13292&type=smp
What are the key forces behind the kyphoscoliosis treatment market’s growth in recent years?
The rising number of spinal cord injuries is expected to propel the growth of the kyphoscoliosis treatment market going forward. Spinal cord injuries refer to any trauma, damage, or harm to the spine’s structures, including the bones (vertebrae), intervertebral discs, ligaments, muscles, nerves, and other supporting structures, which result in the emergence of kyphoscoliosis and ultimately cause alterations in spinal alignment. Treatment for kyphoscoliosis associated with spinal cord injuries involves a comprehensive approach, including orthopedic evaluation, physical therapy, bracing, potential surgery, pain management, and a multidisciplinary healthcare team focusing on patient education and individualized care plans. For instance, in February 2022, according to the Alabama Department of Public Health, a US-based state agency, The ATR received reports of 3,817 neurological injuries involving the head and spinal cord in 2022, compared to 4,734 reported cases in 2021. Therefore, the rising number of spinal cord injuries is driving the growth of the kyphoscoliosis treatment market.
What are the major segments of the kyphoscoliosis treatment market?
The kyphoscoliosis treatment market covered in this report is segmented –
1) By Type: Postural Kyphosis, Scheuermann’s Kyphosis, Congenital Kyphosis
2) By Treatment: Medications, Surgery And Bracing
3) By End-User: Hospital, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Postural Kyphosis: Adolescent Postural Kyphosis, Adult Postural Kyphosis
2) By Scheuermann’s Kyphosis: Adolescent Scheuermann’s Kyphosis, Adult Scheuermann’s Kyphosis
3) By Congenital Kyphosis: Type I Congenital Kyphosis, Type II Congenital Kyphosis, Other Congenital Forms
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/kyphoscoliosis-treatment-global-market-report
Which companies dominate the kyphoscoliosis treatment market?
Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.
What major trends will shape the kyphoscoliosis treatment market during the forecast period?
Major companies operating in the kyphoscoliosis treatment market are developing innovative products, such as the MARVEL growing rod system, designed specifically for early-onset scoliosis. The MARVEL Growing Rod System is a posterior stabilizing rod that may be surgically implanted and periodically stretched by hand-operated mechanical actuation. For instance, in July 2023, Globus Medical Inc., a US-based medical device company, launched MARVEL Growing Rod System. It is intended to help patients under 10 with early-onset scoliosis achieve and sustain correction while permitting ongoing development using minimally invasive distraction. It offers substantial diversion, immediate tactile feedback, and automated locking, enabling dependable growth. One of the cutting-edge items is the Growing Rod System, which is anticipated to aid in the future expansion of the business.
What are the key regional dynamics of the kyphoscoliosis treatment market, and which region leads in market share?
North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Kyphoscoliosis Treatment Market Report 2025 Offer?
The kyphoscoliosis treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Kyphoscoliosis is a spinal condition characterized by abnormal forward curvature (kyphosis) and sideways curvature (scoliosis) of the spine, leading to postural and respiratory problems. The treatment involves medical interventions and therapies to manage and correct the spinal deformity, improve posture, reduce pain, and prevent further spinal curvature.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13292
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
